Site(s) and mechanisms of the anti-emetic action of 5-HT3 receptor antagonists: a discussion of Professor Naylor's paper.
Tyers
M B
MB
Neuropharmacology Department, Glaxo Group Research, Ware, Herts, UK.
D000818:Animals; D000932:Antiemetics / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001933:Brain Stem / Q000187:drug effects / Q000502:physiology; D005289:Ferrets; D006801:Humans; D011878:Radiotherapy / Q000009:adverse effects; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists; D014839:Vomiting / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control
D000932:Antiemetics; D000970:Antineoplastic Agents; D012702:Serotonin Antagonists; D012701:Serotonin